Anquan Shang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
Papers in
-
- Extracellular vesicles in disease 16
- Circular RNAs in diseases 14
- RNA modifications and cancer 10
- Gut microbiota and health 5
-
- MicroRNA in disease regulation 19
- Cancer-related molecular mechanisms research 19
- Co-authors
- Weiwei Wang (38 shared papers)Chenzheng Gu (27 shared papers)Junlu Wu (25 shared papers)Zujun Sun (24 shared papers)Wenying Lu (18 shared papers)Bingjie Zeng (11 shared papers)Ping Ji (17 shared papers)Dong Li (13 shared papers)
- Journals
- Journal of Immunology Research (5 papers)Journal of Oncology (5 papers)Artificial Cells Nanomedicine and Biotechnology (5 papers)Frontiers in Oncology (4 papers)Journal of Cancer (3 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Anquan Shang
85 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 1.1k
- Molecular Biology 1.4k
- Immunology 334
- Oncology 332
- Hepatology 49
Countries citing papers authored by Anquan Shang
This map shows the geographic impact of Anquan Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anquan Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anquan Shang more than expected).
Fields of papers citing papers by Anquan Shang
This network shows the impact of papers produced by Anquan Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anquan Shang. The network helps show where Anquan Shang may publish in the future.
Co-authors
The 25 scholars most cited alongside Anquan Shang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis Hit paper breakdown → | 2020 | 342 |
| 2 | 2019 | 160 | |
| 3 | 2020 | 100 | |
| 4 | 2022 | 93 | |
| 5 | 1996 | 74 | |
| 6 | 2020 | 73 | |
| 7 | 2021 | 61 | |
| 8 | 2019 | 60 | |
| 9 | 2017 | 52 | |
| 10 | 2018 | 50 | |
| 11 | 2020 | 42 | |
| 12 | 2020 | 41 | |
| 13 | 2019 | 39 | |
| 14 | 2021 | 38 | |
| 15 | 2024 | 36 | |
| 16 | 2020 | 35 | |
| 17 | 2022 | 32 | |
| 18 | 2017 | 32 | |
| 19 | 2017 | 32 | |
| 20 | 2021 | 31 |
About Anquan Shang
Anquan Shang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 86 papers that have together received 2.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (19 papers), Extracellular vesicles in disease (16 papers), Circular RNAs in diseases (14 papers), RNA modifications and cancer (10 papers), Ferroptosis and cancer prognosis (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Gut microbiota and health (5 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.4k citations), Immunology (334 citations), Oncology (332 citations) and Hepatology (49 citations). Anquan Shang has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Weiwei Wang, Chenzheng Gu, Junlu Wu, Zujun Sun, Wenying Lu, Bingjie Zeng, Ping Ji, Dong Li, Junjun Sun and Wenqiang Quan. Their work appears in journals such as Journal of Immunology Research, Journal of Oncology, Artificial Cells Nanomedicine and Biotechnology, Frontiers in Oncology and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.